Close

Yuvraj

Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL

Cephalon, Inc. (Nasdaq: CEPH) today announced that Risk Evaluation and Mitigation Strategies (REMS) for its medications NUVIGIL(R) (armodafinil) Tablets and PROVIGIL(R) (modafinil) Tablets...

Pfizer Entering into a partnership with Laboratorio Teuto Brasileiro S.A to develop and commercialize generic medicines

Pfizer Inc. announced that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to...

Sandoz announces launch of piperacillin and tazobactam for injection, a generic version of Zosyn

Sandoz anounced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®, in the US. Piperacillin and tazobactam for injection is...

FDA approves Herceptin for HER2-positive metastatic stomach cancer

Roche announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil )...

Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML

Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to...

Genzyme Reports Financial Results for the Third-quarter revenue was $1.0 billion,

Genzyme Corp. reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection). Patients in the United States began returning to normal...

Romaco Group at PACK EXPO 2010 in Chicago: Ergonomic Packaging Solutions

The Romaco Group will show some of the highlights in its Processing and Packaging lines at the forthcoming PACK EXPO 2010 in Chicago. Romaco's...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read